Jingui Shenqi Wan alleviates bone loss induced by primary osteoporosis by inhibiting osteoblast pyroptosis
Abstract Objective The primary objective of this study was to elucidate the underlying pharmacological mechanisms by which Jingui Shenqi Wan (JGSQW) alleviates postmenopausal osteoporosis (PMOP). Through a systematic investigation, we sought to identify the specific molecular pathways through which...
Saved in:
Main Authors: | Yuwangxuan Qian, Yihe Yu, Fan Yang, Qixing Liang, Dan Xu, Jiaxiang Chen, Xueqin Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Journal of Orthopaedic Surgery and Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13018-025-05542-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dichotomitin promotes osteoblast differentiation and improves osteoporosis by inhibiting oxidative stress
by: Meichun Han, et al.
Published: (2025-01-01) -
Comparative analysis of paraclinical parameters in the assessment of osteoporosis: an integrative approach
by: Oana Raluca Antonescu, et al.
Published: (2025-12-01) -
Elucidating the metabolic mechanisms and active constituents of ZuoGui Wan in combatting postmenopausal osteoporosis: A metabolomics and network pharmacology approach
by: Yanchen Feng, et al.
Published: (2025-02-01) -
Ketogenic diet and β-hydroxybutyrate in osteoporosis: current progress and controversy
by: Changfang Luo, et al.
Published: (2025-01-01) -
Discussion on Research Approaches of Traditional Chinese Medicine Syndromes of Postmenopausal Osteoporosis
by: Yuqing SUN, et al.
Published: (2016-12-01)